Come up with a name for your new list and we'll add to it:
CardiaLen raised a round of funding on February 01, 2013. Investors include
St. Louis Arch Angels.
CardiaLen develops and commercializes pain-free cardioversion therapy, with a primary focus on atrial fibrillation (AF). The company is developing implantable low-energy (low voltage) pain-free atrial…